• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN 11.1% 1.0¢

BIOXYNE LIMITED

Bioxyne Limited is an Australia-based health and wellness products company. Its activity... Bioxyne Limited is an Australia-based health and wellness products company. Its activity is the development, manufacture and distribution of nutritional health and wellness supplements through indirect wholesale and direct sales channels in the health and wellness sector. It is engaged in the consumer dietary supplements and functional foods markets through its probiotic, Lactobacillus fermentum VRI-003 (PCC). The Company has developed a range of functional food and beauty products containing ingredients sourced primarily from New Zealand, through its direct sales business trading as Bioxyne International. It has an interest in Breathe Life Sciences (BLS). It has operations across Australia, the United Kingdom, Japan, Europe and Southeast Asia with a health and wellness product portfolio, including health supplements, skincare, probiotics, cannabis-derived raw materials, starting materials, active pharmaceutical ingredients, cannabinoid-based therapies and telemedicine technology.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BXN
News: BXN Bioxyne Posts HY Loss Attributable A$12.3 Million
29/02/24 0 117
29/02/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  117 
BXN 29/02/24 0 184
29/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  184 
BXN
News: BXN Bioxyne Says Awarded Gmp Manufacturing License For Medical Cannabis
07/02/24 2 854
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
07/02/24 Last post  pakkham Comments Created with Sketch.  2  Views Created with Sketch.  854 
BXN 05/02/24 0 368
05/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  368 
BXN 05/02/24 0 163
05/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  163 
BXN
Bioxyne going places > big orders
31/01/24 6 3.2K
31/01/24 Last post  pakkham Comments Created with Sketch.  6  Views Created with Sketch.  3.2K 
BXN 29/01/24 0 205
29/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  205 
BXN 17/11/23 0 218
17/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  218 

See All Discussions arrow Created with Sketch.

Timeline

Half Yearly Report and Accounts
29 Feb 12:38
 
BXN Awarded GMP Manufacturing License for Medical Cannabis
05 Feb 08:19
 
Quarterly Report Listing Rule 4.7C.3
05 Feb 08:18
 
Quarterly Activities/Appendix 4C Cash Flow Report
29 Jan 08:16
 
Final Director's Interest Notice
17 Nov 16:08
 
Retirement of Director
17 Nov 16:08
 
View More arrow Created with Sketch.
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $19.01M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $2.457K 249.6K

Buyers (Bids)

No. Vol. Price($)
5 730333 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 394510 3
View Market Depth
Last trade - 11.09am 19/03/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.